GlassScriptPhysician profile
Jay P Schwartz
NPI 1699760454
$2,034.25
in general payments reported to CMS, 2019-2025
14 companies · $98.81 in 2025
The $98.81 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $1,529 · 2021: $209 · 2024: $57.57 · 2025: $98.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,248.10 | 2020 | |
| Tris Pharma INC | $184.51 | 2019-2021 | |
| Welch Allyn | $108.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.34 | 2020-2021 | |
| Genentech USA, INC. | $81.52 | 2019-2020 | |
| Pfizer INC. | $69.11 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $44.73 | 2020-2021 | |
| Adlon Therapeutics L.P. | $36.98 | 2020-2021 | |
| Corium, LLC | $35.87 | 2024-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $32.22 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.52 | 2025 | Zoryve |
| Vertical Pharmaceuticals, LLC | $26.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.88 | 2025 | |
| Cranial Technologies, INC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.